Futureproofing [18F]Fludeoxyglucose manufacture at an Academic Medical Center

• Main Authors: Alexandra R Sowa (Author), Isaac M Jackson (Author), Timothy J Desmond (Author), Jeremiah Alicea (Author), Anthony J Mufarreh (Author), Jonathan M Pham (Author), Jenelle Stauff (Author), Wade P Winton (Author), Maria V Fawaz (Author), Bradford D Henderson (Author), Brian G Hockley (Author), Virginia E Rogers (Author), Robert A Koeppe (Author), Peter J H Scott (Author)
• Format: Book
• Published: SpringerOpen, 2018-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background We recently upgraded our [18F]fludeoxyglucose (FDG) production capabilities with the goal of futureproofing our FDG clinical supply, expanding the number of batches of FDG we can manufacture each day, and improving patient throughput in our nuclear medicine clinic. In this paper...